Compare SRTA & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SRTA | IGD |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | 601 | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.3M | 459.0M |
| IPO Year | N/A | N/A |
| Metric | SRTA | IGD |
|---|---|---|
| Price | $4.32 | $5.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.81 | N/A |
| AVG Volume (30 Days) | ★ 648.7K | 261.4K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.27 | N/A |
| Revenue Next Year | $9.09 | N/A |
| P/E Ratio | $9.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.85 | $5.33 |
| 52 Week High | $6.02 | $6.04 |
| Indicator | SRTA | IGD |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 59.89 |
| Support Level | $4.23 | $5.66 |
| Resistance Level | $4.69 | $6.00 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 52.48 | 97.14 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.